Salarius Pharmaceuticals completes merger with Decoy Therapeutics Nov 13, 2025 08:45AM
Salarius Pharmaceuticals and Decoy Therapeutics Complete Merger Nov 13, 2025 08:45AM
Strong Earnings and Biotech Resilience Define the Midweek Momentum Nov 12, 2025 11:00AM
Salarius Pharmaceuticals prices $7 million public offering Nov 11, 2025 09:18AM
Salarius Pharmaceuticals Announces Pricing of $7 Million Underwritten Public Offering Nov 11, 2025 09:18AM


Jan 13, 2025 08:00AM Salarius Pharmaceuticals and Decoy Therapeutics Announce Definitive Merger Agreement
Sep 20, 2022 12:00PM Salarius Pharmaceuticals to Present at the 2022 Ladenburg Thalmann Healthcare Conference
Apr 22, 2022 08:30AM Salarius Pharmaceuticals, Inc. (SLRX) Prices 9.34M Share Direct Offering at $0.25/sh
Apr 22, 2022 08:30AM Salarius Pharmaceuticals, Inc. Announces $2.3 Million Registered Direct Offering
Sep 23, 2021 06:36AM UPDATE: Ladenburg Thalmann Assumes Salarius Pharmaceuticals (SLRX) at Buy
Jul 9, 2021 07:33AM Salarius Pharmaceuticals to Present at the Virtual Ladenburg Thalmann Healthcare Conference
Mar 8, 2021 04:05PM Salarius Announces Closing of $23 Million Underwritten Public Offering of Common Stock Following Full Exercise of Over-Allotment Option
Mar 4, 2021 08:36AM Salarius Pharmaceuticals Inc. (SLRX) Prices 14.6M Share Common Offering at $1.3685/Sh
Mar 4, 2021 08:30AM Salarius Announces Pricing of $20 Million Underwritten Public Offering of Common Stock
Mar 3, 2021 04:05PM Salarius Pharmaceuticals, Inc. (SLRX) Announces Proposed Public Offering of Common Stock
Mar 3, 2021 04:05PM Salarius Announces Proposed Public Offering of Common Stock
Dec 11, 2020 11:32AM Salarius Announces Exercise Of Warrants For $3.5 Million Of Gross Proceeds To Be Used For Ongoing Development Of Seclidemstat
Aug 3, 2020 04:05PM Salarius Announces Closing of $6.2 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option
Jul 30, 2020 09:24AM Salarius Pharmaceuticals, Inc. (SLRX) Announces Pricing of $5.3 Million Underwritten Public Offering of Common Stock
Jul 30, 2020 09:22AM Salarius Announces Pricing of $5.3 Million Underwritten Public Offering
Jul 29, 2020 05:23PM Salarius Pharmaceuticals, Inc. (SLRX) Announces Proposed Public Offering of Common Stock
Jul 29, 2020 04:15PM Salarius Announces Proposed Public Offering of Common Stock
Apr 27, 2020 06:38AM Ladenburg Thalmann Starts Salarius Pharmaceuticals (SLRX) at Buy
Feb 11, 2020 04:05PM Salarius Announces Closing of $11.0 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option
Feb 7, 2020 08:32AM UPDATE: Salarius Pharmaceuticals, Inc. (SLRX) Prices 7.1M Class A Unit Offering at $1.15/Unit
Feb 7, 2020 08:30AM Salarius Announces Pricing of $9.6 Million Underwritten Public Offering